- Home
- A-Z Publications
- Current Pharmaceutical Biotechnology
- Previous Issues
- Volume 12, Issue 8, 2011
Current Pharmaceutical Biotechnology - Volume 12, Issue 8, 2011
Volume 12, Issue 8, 2011
-
-
Editorial [Hot Topic: Potential Application of Peptides in Tumor Targeting and Anticancer Therapeutics (Guest Editor: Jai Prakash)]
By Jai PrakashPeptides own a high potential in the field of cancer because of their high target selectivity and vast applications. Tumor targeted drug delivery has increasingly become an essential step in anticancer therapies as conventional chemotherapies are accompanied with several limitations such as adverse effects and development of drug resistance. Among many targeting approaches, peptide-based carrier systems have contribut Read More
-
-
-
Self-Assembling Peptides: Potential Role in Tumor Targeting
Authors: Parisa Sadatmousavi, M. Soltani, Reyhaneh Nazarian, Mousa Jafari and P. ChenThis review focuses on the application of two classes of peptides, i.e., self-assembling peptides (SAPs) and cell-targeting peptides (CTPs), in the development of nanocarrier delivery systems. Self-assembling peptides are emerging in a wide range of biomedical and bioengineering applications and fall into several classes, including peptide amphiphilies, bolaamphiphile peptides, cyclic peptides, and ionic complement Read More
-
-
-
Anti-Angiogenic Peptides for Cancer Therapeutics
Peptides have emerged as important therapeutics that are being rigorously tested in angiogenesis-dependent diseases due to their low toxicity and high specificity. Since the discovery of endogenous proteins and protein fragments that inhibit microvessel formation (thrombospondin, endostatin) several peptides have shown promise in pre-clinical and clinical studies for cancer. Peptides have been derived from thrombospondin, c Read More
-
-
-
Advances in Methods for Therapeutic Peptide Discovery, Design and Development
Authors: E. Pirogova, T. Istivan, E. Gan and I. CosicDrug discovery and development are intense, lengthy and interdisciplinary processes. Traditionally, drugs were discovered by synthesizing compounds in time-consuming multi-step experimental investigations followed by in vitro and in vivo biological screening. Promising candidates were then further studied for their pharmacokinetic properties, metabolism and potential toxicity. Today, the process of drug discovery h Read More
-
-
-
Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Authors: Angelo Corti and Flavio CurnisVarious peptide sequences have been discovered by selecting peptide-phage display libraries in vitro against specific receptors or in vivo in tumor-bearing animals. One class of these peptides is characterized by the presence of Asn- Gly-Asp (NGR), a structural motif that can recognize the endothelium and other cells of neoangiogenic vessels. Because of this property these peptides have been used by several investigators t Read More
-
-
-
pH-Sensitive PEGylated Liposomes Functionalized With a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cells
Authors: Ashish Garg and Efrosini KokkolipH-sensitive liposomes undergo rapid destabilization under mildly acidic conditions such as those found in endocytotic vesicles. Though this makes them promising drug carriers, their application is limited due to their rapid clearance from circulation by the reticulo-endothelial system. Researchers have therefore used pH-sensitive liposomes that are sterically stabilized by polyethylene glycol (PEG) molecules (stealth lipo Read More
-
-
-
Application of Reproductive Hormone Peptides for Tumor Targeting
Authors: Xiaoyan Zhang and Congjian XuTargeted therapy may be a promising approach against cancer because its focus of attention is to enhance the efficacy and to reduce the side effects of antitumor agents through high selectivity. One of targeted strategies is to use tumor- specific ligands as targeting moieties to carry drugs into tumor cells, and use the receptors that expressed on tumor cells as target sites to bind with peptide ligands. The fact that the distrib Read More
-
-
-
Promises of Apoptosis-Inducing Peptides in Cancer Therapeutics
Authors: David Barras and Christian WidmannUntil recently, most research efforts aimed at developing anti-cancer tools were focusing on small molecules. Alternative compounds are now being increasingly assessed for their potential anti-cancer properties, including peptides and their derivatives. One earlier limitation to the use of peptides was their limited capacity to cross membranes but this limitation was alleviated with the characterization of cell-permeable seq Read More
-
-
-
Cell Penetrating Peptides for Tumor Targeting
Anticancer drug delivery has been hindered due to cell membrane permeability and the lack of a selective marker for tumor cells. Cell permeability is related to the bioavailability of drugs and has therefore been considered to be an essential step for achieving therapeutic efficacy. While different types of transporters currently exist, cell penetrating peptides (CPPs) have become one of the most popular and effective tools for intra Read More
-
-
-
Editorial [Hot Topic: What Have We Learned From Antibiotics? (Guest Editor: James Leif Smith)]
More LessFrom a pragmatic perspective, we are all familiar with the clinical need for antibiotics, and many of us understand the role that antibiotics play in maintaining a safe and abundant food supply. However, the study of antibiotics has also contributed to our fundamental understanding of microbial physiology, which has given us wonderful insights into our own physiology. Antimicrobial “mechanisms of action” and antimicrobial resist Read More
-
-
-
Dermaseptins as Models for the Elucidation of Membrane-Acting Helical Amphipathic Antimicrobial Peptides
Authors: Mohamed Amiche and Cecile GalanthAntimicrobial peptides (AMPs) produced by a wide variety of organisms are major actors of the host defense systems against invading pathogenic microorganisms. These peptides exhibit a broad spectrum of action against bacteria, yeasts, fungi, protozoa and viruses. It is widely believed that a large part of their antimicrobial effect derives from direct interactions with the lipid membrane surrounding the target cells, causing its Read More
-
-
-
Glycopeptide Antibiotics and their Novel Semi-Synthetic Derivatives
Authors: Marimuthu Jeya, Hee-Jung Moon, Kyoung-Mi Lee, In-Won Kim and Jung-Kul LeeGlycopeptide antibiotics, vancomycin and teicoplanin, inhibit cell wall synthesis in Gram-positive bacteria by interacting with peptidoglycan D-Ala-D-Ala peptide stem termini of the pentapeptide side chains of the peptidoglycan precursors. In glycopeptide-resistant bacteria, multiresistance poses major therapeutic problems. New potent antibacterial agents are needed to combat these resistance problems, resulting in the explosio Read More
-
-
-
Are Bacteriocins Underexploited? NOVEL Applications for OLD Antimicrobials
Bacteriocins are ribosomally synthesized (poly)peptides produced by almost all prokaryotic lineages. Bacteriocins from lactic acid bacteria (LAB) and bacteriocin-producer probiotic organisms have been thoroughly studied due to their wide spectra of action, the long-term use in food fermentations and the consideration of these microorganisms as beneficial for human beings. Most of the studies on the biotechnologic Read More
-
-
-
Methodologies and Strategies for the Bioengineering of Lantibiotics
Authors: Jun-ichi Nagao, Mami Nishie and Kenji SonomotoLantibiotics are ribosomally synthesized, post-translationally modified, peptide antibiotics containing unusual amino acids such as dehydrated amino acids and lanthionine. These unusual amino acids impose conformational constraints on the peptide and contribute to the biological activity and high physicochemical stability of lantibiotics. Recent researches on the modification enzymes responsible for dehydration and cyclization Read More
-
-
-
Structural and Functional Diversity of Lantibiotic Immunity Proteins
Authors: Ken-ichi Okuda and Kenji SonomotoLantibiotics are posttranslationally modified antimicrobial peptides produced by some Gram-positive bacteria. After secreting mature lantibiotics, producer cells are at risk for self-destruction. Lantibiotic-producing strains express immunity protein(s) to protect cells against their own products. To date, several types of immunity proteins with diverse structures and functions have been identified. These proteins consist of ABC tra Read More
-
-
-
Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus
Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Read More
-
-
-
Recent Progress on Antifungal Drug Development
Authors: Bing Zhai and Xiaorong LinInvasive fungal infections are a serious threat to public health, particularly to people with compromised or suppressed immunity. Although the current antifungal therapies have been significantly improved, the outcome is still far from satisfactory, partly due to the limited number of classes of clinically available antifungals, the development of resistance to current antifungals, and the challenges of proper and early diagnosis Read More
-
-
-
Survey of Small Antifungal Peptides with Chemotherapeutic Potential
Authors: Andrew P. Desbois, David Tschorner and Peter J. CooteMany cationic peptides with antimicrobial properties have been isolated from bacteria, fungi, plants, and animals. These peptides vary in molecular size, potency and spectra of activities. This report surveyed the literature to highlight the peptides that have antifungal activity and greatest potential for development as new therapeutic agents. Thus, to be included in the evaluation, each peptide had to fulfil the following crite Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cpb
Journal
10
5
false
en
